{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:46:10Z","timestamp":1780105570346,"version":"3.54.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":238,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2021]]},"DOI":"10.6061\/clinics\/2021\/e2830","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:50:35Z","timestamp":1761720635000},"page":"e2830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-5589","authenticated-orcid":false,"given":"Allison A.","family":"Gockley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9603-9783","authenticated-orcid":false,"given":"Lawrence H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6925-9139","authenticated-orcid":false,"given":"Michelle","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-0863","authenticated-orcid":false,"given":"Alexander","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4559-9569","authenticated-orcid":false,"given":"Anthony","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-7386","authenticated-orcid":false,"given":"Sue Yazaki","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-5553","authenticated-orcid":false,"given":"Kevin","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6686-7385","authenticated-orcid":false,"given":"Donald P.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7569-898X","authenticated-orcid":false,"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4854-0642","authenticated-orcid":false,"given":"Neil S.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.6061\/clinics\/2021\/e2830_bib1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMcp0900696","article-title":"Clinical practice. Molar pregnancy","volume":"360","author":"Berkowitz","year":"2009","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.6061\/clinics\/2021\/e2830_bib2","first-page":"S130","article-title":"Trophoblastic disease","volume":"119","author":"Ngan","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.6061\/clinics\/2021\/e2830_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.6061\/clinics\/2021\/e2830_bib4","first-page":"980","article-title":"Is normal beta-hCG regression curve helpful in the diagnosis of persistent trophoblastic disease?","volume":"14","author":"Behtash","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2830_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000073843","article-title":"Criteria for initiating chemotherapy in patients after evacuation of hydatidiform mole","volume":"24","author":"Matsui","year":"2003","journal-title":"Tumor Biol"},{"issue":"3 Pt 1","key":"10.6061\/clinics\/2021\/e2830_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9378(12)90820-0","article-title":"Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve","volume":"168","author":"Yedema","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2830_bib7","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.ajog.2016.04.019","article-title":"Effect of race\/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center","volume":"215","author":"Gockley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2830_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2015.04.030","article-title":"Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia","volume":"138","author":"Maest\u00e1","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"5-6","key":"10.6061\/clinics\/2021\/e2830_bib9","first-page":"254","article-title":"Complete hydatidiform mole in women aged 40 to 49 years","volume":"57","author":"Elias","year":"2012","journal-title":"J Reprod Med"},{"issue":"5-6","key":"10.6061\/clinics\/2021\/e2830_bib10","first-page":"225","article-title":"Molar pregnancy in adolescents","volume":"57","author":"Braga","year":"2012","journal-title":"J Reprod Med"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2830_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/IGC.0000000000000398","article-title":"Response to chemotherapy in overweight\/obese patients with low-risk gestational trophoblastic neoplasia","volume":"25","author":"Maest\u00e1","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.6061\/clinics\/2021\/e2830_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1471-0528.1976.tb00774.x","article-title":"Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole","volume":"83","author":"Stone","year":"1976","journal-title":"Br J Obstet Gynaecol"},{"issue":"8206","key":"10.6061\/clinics\/2021\/e2830_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(80)92510-6","article-title":"Oral contraceptives and post-molar trophoblastic tumours","volume":"2","author":"Bagshawe","year":"1980","journal-title":"Lancet"},{"issue":"8","key":"10.6061\/clinics\/2021\/e2830_bib14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/1471-0528.13617","article-title":"Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review","volume":"123","author":"Braga","year":"2016","journal-title":"BJOG"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2830_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2017.09.007","article-title":"Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?","volume":"147","author":"Dantas","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2830_bib16","first-page":"705","article-title":"Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy","volume":"18","author":"Van Trommel","year":"2006","journal-title":"Int J Mol Med"},{"issue":"9 Pt 2","key":"10.6061\/clinics\/2021\/e2830_bib17","first-page":"3711","article-title":"Obesity, hormones, and cancer","volume":"41","author":"Kirschner","year":"1981","journal-title":"Cancer Res"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2830_bib18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metabol"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2830_bib19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/gme.0b013e3181cec85d","article-title":"Obesity and reproductive hormone levels in the transition to menopause","volume":"17","author":"Freeman","year":"2010","journal-title":"Menopause"},{"issue":"6","key":"10.6061\/clinics\/2021\/e2830_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0039-128X(81)90197-5","article-title":"Failure of contraceptive steroids to modify human chorionic gonadotrophin secretion by hydatidiform mole tissue and choriocarcinoma cells in culture","volume":"37","author":"Gal","year":"1981","journal-title":"Steroids"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2830_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ygyno.2013.09.010","article-title":"p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases","volume":"131","author":"Shoni","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1-2","key":"10.6061\/clinics\/2021\/e2830_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0303-7207(96)03942-1","article-title":"Metabolism of hCG and hLH to multiple urinary forms","volume":"125","author":"Birken","year":"1996","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2830_bib23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2125.2006.02747.x","article-title":"The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate","volume":"63","author":"Atthobari","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.6061\/clinics\/2021\/e2830_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/BF02284965","article-title":"Influence of oral contraceptive agents on kidney function and protein metabolism","volume":"43","author":"Brandle","year":"1992","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222001697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222001697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:57:16Z","timestamp":1761721036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222001697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":24,"alternative-id":["S1807593222001697"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2021\/e2830","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2021\/e2830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e2830"}}